Mitotane, sold under the brand name Lysodren, is a steroidogenesis inhibitor and cytostatic antineoplastic medication which is used in the treatment of adrenocortical carcinoma and …

2025年3月3日 · Mitotane is used to treat cancer of the adrenal gland (adrenal cortical carcinoma). Mitotane may also be used for purposes not listed in this medication guide. Get emergency …

Despite the pivotal role of mitotane in adrenocortical carcinoma (ACC) management, data on the endocrine toxicities of this treatment are lacking. The aim of this systematic review is to collect …

米托坦（Lysodren，mitotane）于1970年获得美国食品药品监督管理局（FDA）批准用于治疗肾上腺皮质癌，并于2004年被欧洲药品管理局（EMA）列为罕见病药物。米托 …

Mitotane is the only reimbursed drug currently approved for adrenocortical carcinoma (ACC), a rare and aggressive malignancy. Despite its clinical use spanning over six decades, the …

Mitotane is used to treat cancer of the adrenal gland that can not be treated with surgery. Mitotane is in a class of medications called antineoplastic agents. It works by slowing growth or …

Mitotane is an adrenal cortex inhibitor used to treat adrenocortical tumors and Cushing's syndrome. Mitotane is an adrenolytic isomer of the insecticide dichlorodiphenyldichloroethane …

Mitotane is used to treat cancer of the adrenal glands (adrenocortical carcinoma) that cannot be removed by surgery. This medicine acts on a part of the body called the adrenal cortex. …

2019年1月7日 · 肾上腺癌唯一的克星米托坦（mitotane） 万邦行健国际医药 2019-01-07. 肾上腺皮质癌(Adrenocortical carcinoma，ACC)是罕见的内分泌恶性肿瘤，预后较差。手术完全切除是 …

Mitotane is also known as Lysodren®. It is used to treat a rare cancer of the adrenal glands called adrenal cortical carcinoma.